8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 DiabetesMatthias Eckhardt, Frank Himmelsbach, Ralf Lotz et al.|Journal of Medicinal Chemistry|2007Cited by 285
Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced ObesityMatthias Kern, Matthias Blüher, Michael Mark et al.|PLoS ONE|2012Cited by 110
3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: A class of potent DPP-4 inhibitorsMatthias Eckhardt, Ralf Lotz, Norbert Hauel et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 40
ChemInform Abstract: 3,5‐Dihydro‐imidazo[4,5‐d]pyridazin‐4‐ones: A Class of Potent DPP‐4 Inhibitors.Matthias Eckhardt, Ralf Lotz, Norbert Hauel et al.|ChemInform|2008Cited by 0